Introducing the Eversense E3® CGM System

It’s time to Break Free from fingersticks* with the Eversense E3 Continuous Glucose Monitoring System.

*Fingersticks still required for calibration and when symptoms do not match sensor glucose readings.

Get Started

Eversense E3 CGM System

Sensor

The sensor is inserted by a trained health care provider in the upper arm and continuously measures glucose for up to 6 months.

Smart Transmitter

Worn over the sensor, the transmitter wirelessly sends data to user’s mobile device; is removable** and rechargeable and provides unique on-body vibe alerts.

Mobile App – iOS and Android

Displays your real-time glucose readings that you can use to treat your diabetes without a fingerstick.* You can also see your time in range, as well as allow up to 5 people to remotely monitor you in real-time.†

Eversense E3 CGM System

The Eversense E3 CGM System is the new long-term CGM that has a sensor that provides up to 6 months of continuous readings. The sensor is changed by your healthcare provider – no more self-insertions.

Long-Term Convenience

One sensor continuously for up to 6 months

Peace of Mind Accuracy

Exceptional accuracy, including with hypoglycemia

Flexibility of Wear

Easy on, easy-off transmitter to fit your lifestyle**

Discreet Alerts

Distinct on-body vibe alerts when high or low

Gentle on skin

Silicone-based, fresh daily adhesive for comfort (no residue)

Readings You Can Count On

Consistent accuracy for up to 6 months with daily calibrations

Get Started

*Fingersticks still required for calibration and when symptoms do not match sensor glucose readings. **There is no glucose data generated when the transmitter is removed. † On a compatible Android or iOS device. For a full list of compatible devices, please visit https://global.eversensediabetes.com/compatibilityeversense/compatibility/

MKT-1101 Rev 4

Disclaimer

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more. For important safety information, see https://global.eversensediabetes.com/safety-info.

The Eversense®XL Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 180 days. It is intended to complement, not replace, fingerstick blood glucose monitoring. The sensor insertion and removal procedures are performed by a health care provider. The Eversense XL CGM System is a prescription device; patients should talk to their health care provider to learn more. For important safety information, see global.eversensediabetes.com/safety-info.